Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)

NCT03485287 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG: Midomafetamine HCl
BEHAVIORAL: Manualized therapy

Sponsor

Resilient Pharmaceuticals